Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIBILI specializes in the development and clinical research of new products for medical therapy and diagnostic imaging, with internationally recognized expertise in ophthalmology—particularly diabetic retinopathy and age-related macular degeneration. It coordinates national/multinational studies, manages data centers certified by ECRIN, leads the European Vision Institute Clinical Research Network (EVICR.net), and provides services from study design to regulatory submission. No proprietary drug programs or direct clinical results are reported. Recognized for innovation in imaging biomarkers. ISO9001 certified; operates under ICH-GCP guidelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIBILI.